Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, India

1 Jun 2023

Abstract excerpt

Background SARS-CoV-2 has evolved rapidly, resulting in the emergence of lineages with a competitive advantage over one another. Co-infections with different SARS-CoV-2 lineages can give rise to recombinant lineages. To date, the XBB lineage is the most widespread recombinant lineage worldwide, with the recently named XBB.1.16 lineage causing a surge in the number of COVID-19 cases in India. Methodology The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37397651
DOI: 10.7759/cureus.39816

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, IndiaPMID 37397651Read ↗

Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 cases in Maharashtra, IndiaSemantic proximity Read ↗

Genomic surveillance of SARS-CoV-2 and emergence of XBB.1.16 variant in RajasthanSemantic proximity Read ↗

Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022–August 2023Semantic proximity Read ↗

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variantSemantic proximity Read ↗

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant VariantSemantic proximity Read ↗

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariantsSemantic proximity Read ↗

Novel Mutations in XBB Variants of SARS-CoV-2 Decipher High Rates of Morbidity Among COVID-19 Patients in South IndiaSemantic proximity Read ↗

Predominance of the recombinant SARS-CoV-2 lineages XBB in Rio Grande do Sul State, Brazil: a genomic surveillance study and impact on vaccine responseSemantic proximity Read ↗

Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023Semantic proximity Read ↗

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.16 variantSemantic proximity Read ↗

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineageSemantic proximity Read ↗

Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.